A Medical Device Daily
Advanced Bionics (Valencia, California), the neuromodulation division of Boston Scientific (Natick, Massachusetts), and The Hearing Solution Group (Singapore), reported their official partnership.
The Hearing Solution Group will advocate Advanced Bionics' cochlear implant devices, helping to further Advanced Bionics' commitment to providing superior service and support for its users throughout Southeast Asia, the company said.
"Our mission is not just about providing the hearing-impaired with the latest innovations in cochlear implant technology," said Robert Gulock, VP, Advanced Bionics, Asia-Pacific. "More importantly, it is about helping make the transition from silence to sound a positive and rewarding experience. Advanced Bionics' and The Hearing Solutions Group's shared commitment to patient care in Southeast Asia will enable us to provide uncompromising service to patients and clinicians."
Advanced Bionics recently introduced the Harmony HiResolution Bionic Ear System. Designed to enhance music appreciation and improve hearing in a variety of difficult listening environments, the Harmony System delivers HiResolution sound with the Fidelity 120 processing feature for unmatched performance, according to the company. The two key components are designed to provide a more natural representation of sound.
The Hearing Solution Group is the largest hearing healthcare provider in Southeast Asia, serving Singapore, Malaysia, Indonesia and Brunei. The organization said it is renowned for providing a spectrum of hearing health care – from counseling to basic and comprehensive audiological assessments to a full range of hearing devices, habilitation and rehabilitation, and service.
Advanced Bionics bills itself as a leading innovator of bionic devices for people with neurological disorders, including deafness and chronic pain. Boston Scientific acquired the company in 2004 (Medical Device Daily, June 2, 2004).
In other agreement news: GenoLogics (San Francisco) reported that it has inked an agreement with Illumina (San Diego) to become a technology partner and participant in IlluminaConnect, a bioinformatics software program established by Illumina for advancing data integration and analysis for the life sciences.
GenoLogics said it would build integrations into Geneus that support Illumina's BeadArray technology platforms and software for both gene expression and genotyping applications. Geneus includes science-specific modules that are purposed for multiple genomics application areas, and is built on an enterprise laboratory information management system (LIMS) platform designed for scientific lab and data management.
The companies said this integration to Illumina software will allow its customers to interconnect the Illumina technologies in their lab with a LIMS and data management system developed specifically to address gene expression and genotyping workflows and genomics applications. This will allow for smooth data flow from one system to another with an integrating LIMS system that acts as the informatics backbone in one or multiple labs, the companies noted.
GenoLogics provides bioinformatics software solutions intended to help life science laboratories specializing in the field of proteomics, genomics, and systems biology research to manage, integrate, and analyze enormous volumes of scientific and lab data. Illumina develops life science tools and systems for large-scale analysis of genetic variation and biological function.